{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:04:25Z","timestamp":1789365865014,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2018YFC1312700"],"award-info":[{"award-number":["2018YFC1312700"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Our previous study suggested CD36 may be a positive regulator of hepatitis B virus (HBV) replication <jats:italic>in vitro<\/jats:italic>. Therefore, the present study aimed to investigate whether circulating soluble CD36 (sCD36) could serve as a diagnostic and prognostic biomarker for HBV-related liver diseases based on the clinic collected data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 282 subjects were divided into healthy controls (HC, <jats:italic>n<\/jats:italic>\u2009=\u200947), chronic hepatitis B (CHB, <jats:italic>n<\/jats:italic>\u2009=\u200968), HBV-related liver cirrhosis (HBV-LC, <jats:italic>n<\/jats:italic>\u2009=\u2009167). Soluble CD36 in plasma was measured by ELISA, and monocyte or platelet CD36 expression was determined by flow cytometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was a step-wise increase of sCD36 with the progression of chronic HBV infection, and it was the highest in the HBV- LC group with liver failure (1.50, IQR:1.04\u20132.00) as compared with HC (0.38, IQR:0.27\u20130.38), CHB (0.75, IQR:0.40\u20131.13), and HBV-LC without liver failure (1.02, IQR,0.61\u20131.35) group. Circulating sCD36 was not correlated with serum HBV DNA levels, but correlated with liver function parameters. Additionally, ROC analysis confirmed sCD36 could be used to predict liver failure for HBV-LC patients, which yielded an AUC of 0.775 with 71.0% sensitivity and 72.2% specificity. Multivariate logistic regression analysis revealed sCD36 is an independent risk factor in predicting liver failure. Moreover, plasma sCD36 in HBV-LC patients was significantly correlated with prognostic indices, including MELD, MELD-Na and CHILD-PUGH scores. On the other hand, CD36 expression on monocytes or platelets was positively correlated with plasma sCD36 levels, whereas they were not strongly associated with the disease severity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Circulating sCD36 could be used as a novel noninvasive biomarker for predicting liver failure and prognosis in chronic HBV infected patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2022.1039614","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T10:00:13Z","timestamp":1667383213000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Chunxian","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enze","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhurong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1538-7836.2011.04220.x","article-title":"The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles","volume":"9","author":"Alkhatatbeh","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.4049\/jimmunol.181.10.7147","article-title":"Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling","volume":"181","author":"Baranova","year":"2008","journal-title":"J. Immunol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0140-6736(15)00309-8","article-title":"Acute-on-chronic liver failure","volume":"386","author":"Bernal","year":"2015","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.freeradbiomed.2021.03.004","article-title":"Circulating CD36 is increased in hyperlipidemic mice: cellular sources and triggers of release","volume":"168","author":"Biswas","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"158658","DOI":"10.1016\/j.bbalip.2020.158658","article-title":"Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma","volume":"1865","author":"Buechler","year":"1865","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.humimm.2014.01.012","article-title":"The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to ox LDL in humans","volume":"75","author":"Chavez-Sanchez","year":"2014","journal-title":"Hum. Immunol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1002\/elps.201200629","article-title":"Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC\/IT-TOF MS","volume":"34","author":"Chen","year":"2013","journal-title":"Electrophoresis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"21808","DOI":"10.1038\/srep21808","article-title":"CD36 is a co-receptor for hepatitis C virus E1 protein attachment","volume":"6","author":"Cheng","year":"2016","journal-title":"Sci. Rep."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3760\/cma.j.issn.1007-3418.2019.12.008","article-title":"The guidelines of prevention and treatment for chronic hepatitis B (2019 version)","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J. Hepatol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jhep.2015.11.021","article-title":"Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)","volume":"64","author":"Gronbaek","year":"2016","journal-title":"J. Hepatol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13293-015-0028-8","article-title":"Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans","volume":"6","author":"Gustafson","year":"2015","journal-title":"Biol. Sex Differ."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2796.2011.02442.x","article-title":"Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population","volume":"271","author":"Handberg","year":"2012","journal-title":"J. Intern. Med."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/ijo.2016.223","article-title":"Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls","volume":"41","author":"Heeboll","year":"2017","journal-title":"Int. J. Obes."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1758-5996-5-51","article-title":"Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease","volume":"5","author":"Himoto","year":"2013","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.yexcr.2017.07.012","article-title":"Fatty acid translocase promoted hepatitis B virus replication by upregulating the levels of hepatic cytosolic calcium","volume":"358","author":"Huang","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e0164787","DOI":"10.1371\/journal.pone.0164787","article-title":"Genome-wide transcriptome analysis of CD36 overexpression in Hep G2.2.15 cells to explore its regulatory role in metabolism and the hepatitis B virus life cycle","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/hep.27129","article-title":"Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C","volume":"60","author":"Kazankov","year":"2014","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1053\/j.gastro.2007.03.039","article-title":"Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma","volume":"132","author":"Kim","year":"2007","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jvh.12224","article-title":"The validity of serum markers for fibrosis staging in chronic hepatitis B and C","volume":"21","author":"Li","year":"2015","journal-title":"J. Viral Hepat."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-018-0908-y","article-title":"HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK\/ERK and PI3K\/AKT signaling pathways","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1038\/srep08421","article-title":"The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.cellsig.2016.05.017","article-title":"Porphyromonas gingivalis infected macrophages upregulate CD36 expression via ERK\/NF-kappa B pathway","volume":"28","author":"Liang","year":"2016","journal-title":"Cell. Signal."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.freeradbiomed.2012.02.012","article-title":"Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients","volume":"52","author":"Liani","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1172\/JCI114188","article-title":"Activation of monocytes and platelets by monoclonal antibodies or Malariainfected erythrocytes binding to the CD36 surface receptor in vitro","volume":"84","author":"Ockenhouse","year":"1989","journal-title":"J. Clin. Invest."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0021-9150(02)00421-5","article-title":"Increased expression of a scavenger receptor (CD36) in monocytes from subjects with type 2 diabetes","volume":"167","author":"Sampson","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13073-016-0318-8","article-title":"Metabolic characterization of the natural progression of chronic hepatitis B","volume":"8","author":"Schoeman","year":"2016","journal-title":"Genome Med."},{"key":"ref1001","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1440-1746.2011.06971.x","article-title":"Acute-on-chronic liver failure in chronic hepatitis B","volume":"27","author":"Seto","year":"2012","journal-title":"J. Gastroenterol Hepatol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mehy.2007.08.032","article-title":"The \"metabolovirus\" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon","volume":"71","author":"Shlomai","year":"2008","journal-title":"Med. Hypotheses"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tem.2008.11.001","article-title":"Cellular fatty acid uptake: a pathway under construction","volume":"20","author":"Su","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-1536-5-S1-S27","article-title":"Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo","volume":"5","author":"Tacke","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J. Hepatol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1478-3231.2005.01042.x","article-title":"Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics","volume":"25","author":"Ventura","year":"2005","journal-title":"Liver International"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2471252","article-title":"Review of serum biomarkers and models derived from them in HBV-related liver diseases","volume":"2020","author":"Wu","year":"2020","journal-title":"Dis. Markers"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1021\/pr400247f","article-title":"Differential regulation of host genes including hepatic fatty acid synthase in HBV-transgenic mice","volume":"12","author":"Zhang","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"403616","DOI":"10.1155\/2015\/403616","article-title":"Puerarin inhibits ox LDL-induced macrophage activation and foam cell formation in human THP1 macrophage","volume":"2015","author":"Zhang","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","article-title":"CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis","volume":"69","author":"Zhao","year":"2018","journal-title":"J. Hepatol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e11049","DOI":"10.1371\/journal.pone.0011049","article-title":"Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis","volume":"5","author":"Zimmermann","year":"2010","journal-title":"PLoS One"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1039614\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T10:00:17Z","timestamp":1667383217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1039614\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":40,"alternative-id":["10.3389\/fmicb.2022.1039614"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.1039614","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"article-number":"1039614"}}